Skip to main content

Ampulla of Vater and Head of Pancreas Carcinomas

  • Chapter
  • First Online:
Histopathology Reporting
  • 765 Accesses

Abstract

Ampulla of Vater and Head of Pancreas Carcinomas: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    A high power field equating to 0.2 mm2 (10hpfs = 2 mm2)

  2. 2.

    The European Neuroendocrine Tumour Society (ENETS) designates pancreatic neuroendocrine tumours as: pT1 < 2 cm (less than 5 mm = microadenoma/benign), pT2 > 2 cm and ≤ 4 cm, pT3 > 4 cm, pT4 invading adjacent large vessels or stomach, spleen, colon or adrenal gland. The ENETS TNM staging system is endorsed by The Royal College of Pathologists

Bibliography

  • Bond-Smith G, Banga N, Hammond TM, Imber CJ. Pancreatic adenocarcinoma. BMJ. 2012;344:45–50.

    Article  CAS  Google Scholar 

  • Bosman FT, Carneiro F. GI WHO classification of tumours. Digestive system tumours. 5th ed.; 2019.

    Google Scholar 

  • British Society of Gastroenterology. Guidelines for the management of patients with pancreatic cancer, periampullary and ampullary carcinomas. Gut. 2005;54:v1–v15.

    Article  Google Scholar 

  • Campbell F, Verbeke CS. Pathology of the pancreas. A practical approach, 2013. Springer.-Verlag. London.

    Google Scholar 

  • Carter D, Russell RCG, Pitt HA, Bismuth H, editors. Rob and Smith’s operative surgery: hepatobiliary and pancreatic surgery. 5th ed. London: Chapman and Hall; 1996.

    Google Scholar 

  • Esposito I, Konukiewitz B, Schlitter AM, Kloppel G. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments. World J Gastroenterol. 2014;20:13833–41.

    Article  Google Scholar 

  • Falconi M, Eriksson B, Kaltsas G, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103:153–71.

    Article  CAS  Google Scholar 

  • Garcia-Carbonero R, Sorbye H, Baudin E, et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103:186–94.

    Article  CAS  Google Scholar 

  • Haugk B. Pancreatic intraepithelial neoplasia – can we detect early pancreatic cancer? Histopathology. 2010;57:503–14.

    Article  Google Scholar 

  • Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. In: Atlas of tumor pathology. 4th ed.. Fascicle 6. Washington: AFIP; 2007.

    Google Scholar 

  • Hong SM, Park JY, Hruban RH, Goggins M. Molecular signatures of pancreatic cancer. Arch Pathol Lab Med. 2011;135:716–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jun SY, Hong SM. Nonductal pancreatic cancers. Surg Pathol Clin. 2016;9:581–93.

    Article  Google Scholar 

  • Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388:73–85.

    Google Scholar 

  • Lloyd RV, Osamura RY, Kloppel G, et al. WHO classification of tumours of endocrine organs. 4th ed. Lyon: World Health Organization Classification of Tumours. International Agency for Research on Cancer (IARC); 2017.

    Google Scholar 

  • Luchini C, Capelli P, Scarpa A. Pancreatic ductal adenocarcinoma and its variants. Surg Pathol Clin. 2016;9:547–60.

    Article  Google Scholar 

  • McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24:4846–61.

    Article  Google Scholar 

  • O’Reilly D, Fou L, Hasler E, et al. Diagnosis and management of pancreatic cancer in adults: a summary of guidelines from the UK National Institute for health and care excellence. Pancreatology. 2018;18:962–70.

    Article  Google Scholar 

  • Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine including carcinoid tumours (NETs). Gut. 2012;61:6–32.

    Article  CAS  Google Scholar 

  • Reid MD, Saka B, Balci S, Goldblum AS, Adsay NV. Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications. Am J Clin Pathol. 2014;141:168–80.

    Article  CAS  Google Scholar 

  • The Royal College of Pathologists. Cancer Datasets (Oesophageal Carcinoma, Gastric Carcinoma, Carcinomas of the Pancreas, ampulla of Vater and Common Bile Duct, Colorectal Cancer, Gastrointestinal Stromal Tumours (GISTs), Liver Resection Specimens and Liver Biopsies for Primary and Metastatic Carcinoma, Endocrine Tumours of the Gastrointestinal Tract including Pancreas) and Tissue Pathways (Gastrointestinal and Pancreatobiliary Pathology, Liver Biopsies for the Investigation of Medical Disease and for Focal Liver Lesions). Accessed at https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html

  • Verbeke CS. Resection margins in pancreatic cancer. Surg Clin North Am. 2013;93:647–62.

    Article  Google Scholar 

  • Verbeke CS, Knapp J, Gladhaug IP. Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment. Histopathology. 2011;59:1111–21.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul J. Kelly .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kelly, P.J. (2020). Ampulla of Vater and Head of Pancreas Carcinomas. In: Boyle, D., Allen, D. (eds) Histopathology Reporting. Springer, Cham. https://doi.org/10.1007/978-3-030-27828-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27828-1_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27827-4

  • Online ISBN: 978-3-030-27828-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics